CAS 101-26-8
:Pyridostigmine bromide
Description:
Pyridostigmine bromide is a synthetic compound classified as a reversible inhibitor of the enzyme acetylcholinesterase, which plays a crucial role in the breakdown of the neurotransmitter acetylcholine. This compound is primarily used in the treatment of myasthenia gravis, a neuromuscular disorder characterized by weakness in the skeletal muscles. Pyridostigmine bromide enhances communication between nerves and muscles by increasing acetylcholine levels at the neuromuscular junction, thereby improving muscle strength and endurance. It is typically administered orally and is known for its relatively long duration of action compared to other similar agents. The compound appears as a white to off-white crystalline powder and is soluble in water, making it suitable for various formulations. Additionally, it has been studied for its potential use in counteracting the effects of nerve agents and as a prophylactic treatment in certain military contexts. As with any medication, it may have side effects, including gastrointestinal disturbances and increased salivation, necessitating careful monitoring during use.
Formula:C9H13N2O2·Br
InChI:InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1
InChI key:InChIKey=VNYBTNPBYXSMOO-UHFFFAOYSA-M
SMILES:O(C(N(C)C)=O)C1=C[N+](C)=CC=C1.[Br-]
Synonyms:- 1-Methyl-3-hydroxypyridinium bromide dimethylcarbamate
- 3-(Dimethylcarbamyloxy)-1-methylpyridinium bromide
- 3-Dimethylcarbamoyloxy-1-Methylpyridinium Bromide
- 3-Hydroxy-1-methylpyridinium bromide, dimethylcarbamate
- 3-[[(Dimethylamino)carbonyl]oxy]-1-methylpyridinium bromide
- Carbamic acid, dimethyl-, ester with 3-hydroxy-1-methylpyridinium bromide
- Kalimin
- Kalymin
- Mestinon
- Mestinon bromide
- NSC 679759
- Piridostigmin
- Piridostigmin bromide
- Pyridinium, 3-[[(dimethylamino)carbonyl]oxy]-1-methyl-, bromide
- Pyridinium, 3-[[(dimethylamino)carbonyl]oxy]-1-methyl-, bromide (1:1)
- Pyridinium, 3-hydroxy-1-methyl-, bromide, dimethylcarbamate
- Pyridostigmine Bromine
- Regonol
- See more synonyms
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 20 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Pyridostigmine Bromide
CAS:Formula:C9H13BrN2O2Purity:>98.0%(HPLC)(T)Color and Shape:White to Almost white powder to crystalMolecular weight:261.12PYRIDOSTIGMINE BROMIDE CRS
CAS:PYRIDOSTIGMINE BROMIDE CRSFormula:C9H13BrN2O2Color and Shape:Crystalline Powder. White. Powder.Molecular weight:261.1157Pyridostigmine bromide
CAS:Pyridostigmine bromideFormula:C9H13BrN2O2Purity:99.4%Color and Shape:WhiteMolecular weight:260.01604Pyridostigmine Bromide
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C9H13BrN2O2Color and Shape:White Off-White PowderMolecular weight:260.01604Pyridostigmine bromide
CAS:Pyridostigmine bromideFormula:C9H13BrN2O2Purity:99.5%Molecular weight:261.12Pyridostigmine Bromide
CAS:Formula:C9H13N2O2·BrColor and Shape:White To Off-White SolidMolecular weight:181.22 79.90Pyridostigmine bromide
CAS:Pyridostigmine bromide (Mestinon), a cholinesterase inhibitor, is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.Formula:C9H13BrN2O2Purity:99.00% - 99.98%Color and Shape:White Or Practically White Crystalline Powder Pale Yellow To Colorless LiquidMolecular weight:261.12Pyridostigmine Bromide
CAS:Controlled ProductFormula:C9H13N2O2·BrColor and Shape:NeatMolecular weight:261.123-(Dimethylcarbamoyloxy)-1-Methylpyridinium Bromide
CAS:Formula:C9H13BrN2O2Purity:97%Color and Shape:SolidMolecular weight:261.1157Pyridostigmine Bromide
CAS:Controlled ProductStability Hygroscopic
Applications Cholinergic, used in the treatment of myasthenia gravis, and is a pre-exposure antidote to chemical warfare agents.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Kayihan, G., et al.: Toxicol. Environ. Chem., 92, 1783 (2010), Yu, Q., et al.: Bioorg. Med. Chem., 18, 4687 (2010), Voicu, V., et al.: J. Pharm. Biomed. Anal., 52, 508 (2010),Formula:C9H13N2O2·BrColor and Shape:NeatMolecular weight:261.123-((Dimethylcarbamoyl)oxy)-1-methylpyridin-1-ium bromide
CAS:3-((Dimethylcarbamoyl)oxy)-1-methylpyridin-1-ium bromideFormula:C9H13BrN2O2Purity:99+%Molecular weight:261.12Pyridostigmine bromide
CAS:Formula:C9H13BrN2O2Purity:98.5 - 101.5 % (dried basis)Color and Shape:White to off-white crystalline powderMolecular weight:261.123-[(dimethylcarbamoyl)oxy]-1-methylpyridin-1-ium bromide
CAS:Formula:C9H13BrN2O2Purity:97%Molecular weight:261.119Pyridostigmine-d3 Bromide (1-methyl-d3)
CAS:Controlled ProductApplications Pyridostigmine-d3 Bromide (1-methyl-d3) is a useful isotopically labeled compound of Pyridostigmine Bromide (P991705)
Formula:C9D3H10N2O2·BrColor and Shape:NeatMolecular weight:264.134Pyridostigmine bromide
CAS:Pyridostigmine bromideFormula:C9H13BrN2O2Color and Shape:WhiteMolecular weight:261.1157Pyridostigmine bromide
CAS:Controlled ProductPyridostigmine bromide is a cholinergic drug that inhibits the enzyme acetylcholinesterase in the central and peripheral nervous systems. This inhibition leads to an increase in the neurotransmitter acetylcholine, which has an anti-inflammatory effect on cytokine production. Pyridostigmine bromide is used to treat gastrointestinal disorders, such as bowel disease. It also has been shown to be effective against infectious diseases, such as tuberculosis, because of its ability to inhibit proinflammatory cytokines such as IL-10 and TNF-α. Pyridostigmine bromide can be used as an experimental model for inflammatory bowel disease because it is minimally toxic and does not have any phase transition temperature in the human serum.Formula:C9H13BrN2O2Color and Shape:PowderMolecular weight:261.12 g/molRef: 3D-FP27317
Discontinued product
![3-[(dimethylcarbamoyl)oxy]-1-methylpyridin-1-ium bromide](https://static.cymitquimica.com/products/10/thumb/F358103.jpg)
